Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2001 1
2007 2
2008 2
2009 3
2010 2
2011 1
2013 1
2014 3
2015 3
2018 1
2019 1
2020 2
2021 6
2022 4
2023 3
2024 6
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study.
Giacobbe DR, Labate L, Russo Artimagnella C, Marelli C, Signori A, Di Pilato V, Aldieri C, Bandera A, Briano F, Cacopardo B, Calabresi A, Capra Marzani F, Carretta A, Cattelan A, Ceccarelli L, Cenderello G, Corcione S, Cortegiani A, Cultrera R, De Rosa FG, Del Bono V, Del Puente F, Fanelli C, Fava F, Francisci D, Geremia N, Graziani L, Lombardi A, Losito AR, Maida I, Marino A, Mazzitelli M, Merli M, Monardo R, Mularoni A, Oltolini C, Pallotto C, Pontali E, Raffaelli F, Rinaldi M, Ripa M, Santantonio TA, Serino FS, Spinicci M, Torti C, Trecarichi EM, Tumbarello M, Mikulska M, Giacomini M, Marchese A, Vena A, Bassetti M; CEFI-SITA investigators. Giacobbe DR, et al. Infect Dis Ther. 2024 Sep;13(9):1929-1948. doi: 10.1007/s40121-024-01016-y. Epub 2024 Jul 12. Infect Dis Ther. 2024. PMID: 38995601 Free PMC article.
The Medical Impact of Hepatitis D Virus Infection in Natives and Immigrants: The Italian Paradigm.
Caviglia GP, Dileo E, Olivero A, Mengozzi G, Ciancio A, Loglio A, Viganò M, Fagiuoli S, Colombatto P, Coco B, Brunetto MR, Angrisani D, Galeota Lanza A, Magni C, Rizzardini G, Messina V, Milella M, Saracino A, Marinaro L, Cariti G, Cossiga V, Morisco F, Cretella S, Verucchi G, Biliotti E, D'Offizi G, Feasi M, Pontali E, Coppola C, Rapetti R, Pirisi M, Izzi A, Santantonio T, Di Marco V, Marrone A, Coppola N, Rizzi M, Cattelan AM, Niro GA, Toniutto P, Ponziani FR, Belli LS, Federico A, Bertino G, Barone M, Puoti M, Civolani A, Distefano M, Surace LA, Cozzolongo R, Cela EM, Teti E, Lampertico P, Stroffolini T, Rizzetto M; HDV Describe Study Group. Caviglia GP, et al. Among authors: feasi m. Liver Int. 2025 Sep;45(9):e70242. doi: 10.1111/liv.70242. Liver Int. 2025. PMID: 40729522 Free PMC article.
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry.
Armenia D, Spagnuolo V, Bellocchi MC, Galli L, Duca L, Marchegiani G, Clemente T, Carioti L, Lolatto R, Calza L, Celesia BM, Cascio A, Francisci D, Saracino A, Torti C, Zazzi M, Castagna A, Santoro MM; PRESTIGIO Study Group. Armenia D, et al. J Antimicrob Chemother. 2024 Sep 3;79(9):2354-2363. doi: 10.1093/jac/dkae236. J Antimicrob Chemother. 2024. PMID: 39004997
Erysipelothrix rhusiopathiae intra-abdominal abscess.
Feasi M, Bacigalupo L, Cappato S, Pontali E, Usiglio D, Rollandi GA, Filauro M, Mori M, Cassola G. Feasi M, et al. Int J Infect Dis. 2010 Jan;14(1):e81-3. doi: 10.1016/j.ijid.2009.03.008. Epub 2009 May 29. Int J Infect Dis. 2010. PMID: 19481488 Free article.
Down Syndrome and COVID-19: not always a poor prognosis.
Parisini A, Boni S, Vacca EB, Del Puente F, Feasi M, Bobbio N, Prinapori R, Bolla C, Castellaneta M, Pontali E, Chichino G. Parisini A, et al. Among authors: feasi m. Int J Tuberc Lung Dis. 2022 Jul 1;26(7):691-693. doi: 10.5588/ijtld.22.0192. Int J Tuberc Lung Dis. 2022. PMID: 35768929 No abstract available.
Cefiderocol therapy among immunocompromised adult patients: a descriptive analysis from a prospective, multicentre cohort study.
Lombardi A, Giacobbe DR, Mangioni D, Mariani B, Muscatello A, Muccio M, Aldieri C, Briano F, Cacopardo B, Calabresi A, Capra Marzani F, Carretta A, Cattelan A, Ceccarelli L, Cenderello G, Corcione S, Cortegiani A, Cultrera R, De Rosa FG, Del Bono V, Del Puente F, Fanelli C, Fava F, Francisci D, Geremia N, Graziani L, Losito AR, Maida I, Marino A, Mazzitelli M, Merli M, Monardo R, Mularoni A, Oltolini C, Pallotto C, Pontali E, Raffaelli F, Rinaldi M, Ripa M, Santantonio TA, Serino FS, Spinicci M, Torti C, Trecarichi EM, Tumbarello M, Mikulska M, Vena A, Bandera A, Bassetti M; CEFI-SITA investigators. Lombardi A, et al. BMC Infect Dis. 2025 Oct 16;25(1):1339. doi: 10.1186/s12879-025-11573-3. BMC Infect Dis. 2025. PMID: 41102622 Free PMC article.
Persistence of CXCR4-tropic virus in people living with four-class drug-resistant HIV and its clinical impact in the modern antiretroviral era.
Papaioannu Borjesson R, Diotallevi S, Lolatto R, Cenderello G, Comi L, Cascio A, Saracino A, Clemente T, Mazzitelli M, Lo Caputo S, Armenia D, Santoro MM, Castagna A, Spagnuolo V; PRESTIGIO Study Group. Papaioannu Borjesson R, et al. J Antimicrob Chemother. 2025 Sep 3;80(9):2369-2374. doi: 10.1093/jac/dkaf211. J Antimicrob Chemother. 2025. PMID: 40693490
45 results